Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells

Mediators of Inflammation

Volumn 2008, Issue , 2008, Pages

  Garbin, Ulisse ^a   Fratta Pasini, Anna ^a   Stranieri, Chiara ^a   Manfro, Stefania ^a   Mozzini, Chiara ^a   Boccioletti, Veronica ^a   Pasini, Andrea ^a   Cominacini, Mattia ^a   Evangelista, Stefano ^b   Cominacini, Luciano ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Preclinical Development   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 6; NEBIVOLOL; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; BENZOPYRAN DERIVATIVE; CELL ADHESION MOLECULE; ETHANOLAMINE DERIVATIVE; ICAM2 PROTEIN, HUMAN; ICAM3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; UMBILICAL VEIN; UPREGULATION; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM;

ANTIGENS, CD; ATENOLOL; BENZOPYRANS; CELL ADHESION MOLECULES; CELLS, CULTURED; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOLAMINES; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; P-SELECTIN; UMBILICAL VEINS;

EID: 44949090646     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2008/367590     Document Type: Article

References (38)

1. Bundkirchen A., Brixius K., Bölck B., Nguyen Q., Schwinger R. H. G., β 1 -adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3h] CGP 12.177 and [125i] iodocyanopindolol binding studies European Journal of Pharmacology 2003 460 1 19 26
2. Ignarro L. J., Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation β -blocker Blood Pressure 2004 13 4, supplement 1 2 16
3. Cominacini L., Pasini A. F., Garbin U., Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation Journal of the American College of Cardiology 2003 42 10 1838 1844
4. Pasini A. F., Garbin U., Nava M. C., Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation Journal of Hypertension 2005 23 3 589 596
5. Mason R. P., Kalinowski L., Jacob R. F., Jacoby A. M., Malinski T., Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans Circulation 2005 112 24 3795 3801
6. Evangelista S., Garbin U., Pasini A. F., Stranieri C., Boccioletti V., Cominacini L., Effect of dl-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells Pharmacological Research 2007 55 4 303 309
7. Oelze M., Daiber A., Brandes R. P., Nebivolol prevents NADPH oxidase mediated superoxide formation and endothelial dysfunction in angiotensin II-treated rats Hypertension 2006 48 4 677 684
8. Babior B. M., NADPH oxidase: an update Blood 1999 93 5 1464 1476
9. de Groot A. A., Mathy M.-J., van Zwieten P. A., Peters S. L. M., Antioxidant activity of nebivolol in the rat aorta Journal of Cardiovascular Pharmacology 2004 43 1 148 153
10. Kunsch C., Medford R. M., Oxidative stress as a regulator of gene expression in the vasculature Circulation Research 1999 85 8 753 766
11. Griendling K. K., Sorescu D., Lassegue B., Ushio-Fukai M., Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology Arteriosclerosis Thrombosis Vascular Biology 2000 20 10 2175 2183
12. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R., Culture of human endothelial cells derived from umbilical veins Journal of Clinical Investigation 1973 52 11 2745 2752
13. Smith P. K., Krohn R. I., Hermanson G. T., Measurement of protein using bicinchoninic acid Analytical Biochemistry 1985 150 1 76 85
14. Landegren U., Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens Journal of Immunological Methods 1984 67 2 379 388
15. Havel R. J., Eder H. A., Bragdon J. M., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum Journal of Clinical Investigation 1955 34 9 1345 1353
16. Cominacini L., Pasini A. F., Garbin U., Oxidized low density lipoproteins (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF- κB through an increased production of intracellular reactive oxygen species Journal of Biological Chemistry 2000 275 17 12633 12638
17. Sharif S., Arreaza G. A., Zucker P., Activation of natural killer T cells by α -galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes Nature Medicine 2001 7 9 1057 1062
18. Galle J., Hansen-Hagge T., Wanner C., Seibold S., Impact of oxidized low density lipoprotein on vascular cells Atherosclerosis 2006 185 2 219 226
19. Libby P., Inflammation in atherosclerosis Nature 2002 420 6917 868 874
20. Sukhanov S., Delafontaine P., Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells Proteomics 2005 5 5 1274 1280
21. Levula M., Jaakkola O., Luomala M., Nikkari S. T., Lehtimäki T., Effects of oxidized low- and high-density lipoproteins on gene expression of human macrophages Scandinavian Journal of Clinical and Laboratory Investigation 2006 66 6 497 508
22. Wolf S. C., Sauter G., Jobst J., Kempf V. A., Risler T., Brehm B. R., Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment International Journal of Cardiology 2008 125 1 4 10
23. Dong Z. M., Chapman S. M., Brown A. A., Frenette P. S., Hynes R. O., Wagner D. D., The combined role of P- and E-selectins in atherosclerosis Journal of Clinical Investigation 1998 102 1 145 152
24. Johnson R. C., Chapman S. M., Dong Z. M., Absence of P-selectin delays fatty streak formation in mice Journal of Clinical Investigation 1997 99 5 1037 1043
25. Cominacini L., Pasini A. F., Garbin U., Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control Diabetologia 1995 38 9 1122 1124
26. Boulbou M. S., Koukoulis G. N., Makri E. D., Petinaki E. A., Gourgoulianis K. I., Germenis A. E., Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension International Journal of Cardiology 2005 98 1 39 44
27. Madej A., Okopien B., Kowalski J., Haberka M., Herman Z. S., Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension Pharmacological Reports 2005 57 6 878 881
28. Ridker P. M., Hennekens C. H., Roitman-Johnson B., Stampfer M. J., Allen J., Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men The Lancet 1998 351 9096 88 92
29. Brehm B. R., Bertsch D., Von Fallois J., Wolf S. C., β -blockers of the third generation inhibit endothelin I liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells Journal of Cardiovascar Pharmacology 2000 36 5, supplement 1 S401 S403
30. Granger J. P., An emerging role for inflammatory cytokines in hypertension American Journal of Physiology 2006 290 3 H923 H924
31. Tarighi B., Kurum T., Demir M., Azcan S. N., The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients Canadian Journal of Cardiology 2007 23 8 651 655
32. Nicholl S. M., Roztocil E., Davies M. G., Plasminogen activator system and vascular disease Current Vascular Pharmacology 2006 4 2 101 116
33. Zaltsman A. B., George S. J., Newby A. C., Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 7 1700 1707
34. Blann A. D., Tse W., Maxwell S. J. R., Waite M. A., Increased levels of the soluble adhesion molecule E-selectin in essential hypertension Journal of Hypertension 1994 12 8 925 928
35. Galis Z. S., Khatri J. J., Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circulation Research 2002 90 3 251 262
36. Wu T.-C., Chen Y.-H., Leu H.-B., Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis Free Radical Biology and Medicine 2007 43 11 1508 1522
37. Mollnau H., Schulz E., Daiber A., Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 615 621
38. Wolf S. C., Sauter G., Preyer M., Influence of nebivolol and metoprolol on inflammatory mediators in human coronary endothelial or smooth muscle cells. Effects on neointima formation after balloon denudation in carotid arteries of rats treated with nebivolol Cellular Physiology and Biochemistry 2007 19 1-4 129 136